| Literature DB >> 32557107 |
Maria Grazia Chiarilli1, Andrea Delli Pizzi2, Domenico Mastrodicasa3, Maria Pia Febo2, Beatrice Cardinali2, Bruno Consorte2, Antonietta Cifaratti2, Valentina Panara2, Massimo Caulo2, Giovanni Cannataro2.
Abstract
Magnetic resonance imaging (MRI) plays a leading role in the non-invasive evaluation of bone marrow (BM). Normal BM pattern depends on the ratio and distribution of yellow and red marrow, which are subject to changes with age, pathologies, and treatments. Neonates show almost entirely red marrow. Over time, yellow marrow conversion takes place with a characteristic sequence leading to a red marrow persistence in proximal metaphyses of long bones. In adults, normal BM is composed of both red (40% water, 40% fat) and yellow marrow (15% water, 80% fat). Due to the higher content of fat, yellow marrow normally appears hyperintense on T1-weighted (T1w) fast spin echo (FSE) sequences and hypo-/iso-intense in short tau inversion recovery (STIR) T2-weighted (T2w); red marrow appears slightly hyperintense in T1w FSE and hyper-/iso-intense in STIR T2w. Pathologic BM has reduced fat and increased water percentages, resulting hypointense in T1w FSE and hyperintense in STIR T2w. In oncologic patients, BM MRI signal largely depends on the treatment (irradiation and/or chemotherapy) and its timing. BM fat and water amount and location in normal red/yellow and pathologic marrow are responsible for different signals in MRI sequences whose knowledge by radiologists may help to differentiate between normal and pathologic findings. Our aim was to discuss and illustrate the MRI of BM physiologic conversion and pathologic reconversion occurring in malignancies and after treatments in cancer patients.Entities:
Keywords: Bone marrow; Chemotherapy; Differential diagnosis; Magnetic resonance imaging; Musculoskeletal system spine imaging; Radiotherapy
Mesh:
Year: 2020 PMID: 32557107 DOI: 10.1007/s11547-020-01239-2
Source DB: PubMed Journal: Radiol Med ISSN: 0033-8362 Impact factor: 6.313